RxDoctor Payments Data

Ana-Maria Benefield, MD

Family Medicine · Oxford, MSNPI 1083118277

Payments from drug & device makers

$2,631in general payments, 2019–2025

Across 144 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$437
  • Inspire Medical Systems, Inc.$335
  • Novo Nordisk$222
  • Lilly USA, LLC$219
  • AstraZeneca$217
  • Pfizer$207
  • plus $994 from 24 others

What the payments were for

  • Food & beverage$2,631100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,631 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$155,814
Medicare patients
473
Services billed
4,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide23$31,679
JardianceEmpagliflozin32$31,268
FarxigaDapagliflozin Propanediol29$27,865
MounjaroTirzepatide18$18,275
Tresiba Flextouch U-200Insulin Degludec17$15,043
EliquisApixaban22$13,574
GemtesaVibegron21$9,708
MyrbetriqMirabegron11$4,935
SymbicortBudesonide/Formoterol Fumarate14$4,002
SynthroidLevothyroxine Sodium21$2,314
Gabapentin126$2,004
PaxlovidNirmatrelvir/Ritonavir14$1,429
Potassium Chloride57$1,312
Rosuvastatin Calcium129$1,296
Albuterol Sulfate HfaAlbuterol Sulfate34$1,271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$217$31,86743 claims
Novo NordiskOzempic$222$31,67923 claims
Boehringer IngelheimJardiance$437$31,26832 claims
Lilly USA, LLCMounjaro$219$18,27518 claims
PfizerEliquis, Paxlovid$207$15,00336 claims
Sumitomo Pharma America, Inc.Gemtesa$38$9,70821 claims
AbbVieSynthroid$113$2,31421 claims
Almatica Pharma LLCSertraline Hcl$17$59256 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →